Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Ayurcann Holdings Corp C.AYUR

Alternate Symbol(s):  AYURF

Consumer Cyclical Packaging & Containers
Ayurcann Holdings Corp. is a Canada-based cannabis extraction company. The Company is specialized in the processing and manufacturing of pharma grade cannabis and hemp for various derivative cannabis products. The Company, through its wholly owned subsidiary, Ayurcann Inc, is a licensed producer focused on providing cannabis products in verity of categories for the recreational and medical use... see more

CSE:AYUR - Post Discussion

Ayurcann Holdings Corp > Still feasible with evidence
View:
Post by JackBauer on Oct 04, 2024 11:14pm

Still feasible with evidence

Acquisition is still feasible even with Arogo being on the OTC.  Plenty of large international companies list on the OTC for American exposure.

Continued quarterly growth from AYUR and a slight reduction in payables hopefully showing in the upcoming financials would help de-risk this as well.

Anyone else have any recent and verifiable DD that could be relevant?
Be the first to comment on this post
Ayurcann Holdings Corp
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities